Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/23/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong David Beier?

David W. Beier

Senior Vice President of Global Government and Corporate Affairs

Amgen Inc.

HQ Phone:  (805) 447-1000

Direct Phone: (805) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Amgen Inc.

One Amgen Center Dr.

Thousand Oaks, California,91320

United States

Company Description

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to u... more

Find other employees at this company (26,174)

Background Information

Employment History

Managing Director

Bay City Capital LLC


Chief Domestic Policy Advisor, Office of the Vice President

Travel Business Roundtable


Counsel

House Judiciary Committee


Senior Vice President, Global Government Affairs

China Inc


Position, Health Care and Technology Fields

Hogan & Hartson LLP


Chief Domestic Policy Adviser To the Vice President

The White House


Vice President of Government Affairs and Public Policy

Genentech , Inc.


Affiliations

The Constitution Project

Board Member


U.S. House of Representatives

Counsel To the Committee


The Center for Global Enterprise

Senior Fellow


CSGV

Board Member


Children's Hospital

Board Member


National Health Council Inc

Board Member


Children's Charities Foundation

Board Member


California Healthcare Institute Inc

Board Member


Keystone Science School

Trustee


SA Worldview

BOARD OF ADVISERS Member


Governance Committee

Member


Committee Composition Documents

Board Member


Fremont

Member, Board


Deltagen , Inc.

Board Member


VaxGen , Inc.

Board Member


Vice President

Chief Domestic Policy Advisor


Republicans

Gore's Chief Domestic Policy Advisor


U.S. House of Representatives

Counsel To the Committee


ARYx Therapeutics Inc.

Board Member


Advisory Committee on Trade Policy and Negotiations

Member


Education

B.A.

Colgate University


J.D.

Albany Law School


Web References(174 Total References)


Board of Directors | The Constitution Project

www.constitutionproject.org [cached]

David Beier
Bay City Capital, LLC David W. Beier, JD, has been Managing Director at Bay City Capital LLC since March, 2013. He previously served as Senior Vice President... Read more


About Us - Coalition to Stop Gun Violence

csgv.org [cached]

David Beier
David Beier, JD is a Managing Director with Bay City Capital, and has been with the firm since 2013. David served as a senior officer for nearly a decade in each of the two largest biotechnology firms, Genentech and Amgen. Most recently, Mr. Beier was a member of the senior management team at Amgen. As Senior Vice President, he had responsibility for global government affairs, as well as corporate communications, and philanthropy. During his Amgen tenure he also helped create and supervised the firm's coverage, reimbursement, access, pricing, and healthcare economics activities globally. Earlier in his career, he was Chief Domestic Policy Advisor to the Vice President in the Clinton Administration. Mr. Beier has been a partner in a large international law firm as well as Counsel to the US House of Representatives Committee on the Judiciary. He is admitted to practice law in New York and the District of Columbia.


CHI 2012 - CHI

www.chi.org [cached]

David Beier, Senior Vice President, Amgen


Bay City Capital :: People / Bio

www.baycitycapital.com [cached]

David Beier, JD
Bay City Capital :: People / Bio Bay City Capital Logo David Beier, JD is a Managing Director of Bay City Capital and has been with the firm since 2013. He served as a senior officer for nearly a decade in each of the two largest biotechnology firms, Genentech and Amgen. Most recently, Mr. Beier was a member of the senior management team at Amgen. As Senior Vice President, he had responsibility for global government affairs, as well as corporate communications, and philanthropy. During his Amgen tenure he also helped create and supervised the firm's coverage, reimbursement, access, pricing, and healthcare economics activities globally. Earlier in his career, he was Chief Domestic Policy Advisor to the Vice President in the Clinton Administration. Mr. Beier has been a partner in a large international law firm as well as Counsel to the US House of Representatives Committee on the Judiciary. He is admitted to practice law in New York and the District of Columbia.


www.biotech-now.org

During the keynote lunch of the China Day special program at the 2012 BIO International Convention, David W. Beier, senior vice president at Amgen and former chief domestic policy advisor to Vice President Al Gore, outlined the 5 keys to making biotech flourish in China.
"The Chinese government has, as part of the 5-year plan, put its stamp of approval on 5 industries: biotechnology… is one of those," Beier said. "Those 7 industries together are targeted with $600 billion, with a 'B,' worth of investment in the 5-year timeframe. A substantial part of the investment is going to be in biology." 2. Investment in a Science-Based Regulatory Environment "The Chinese FDA needs to have its standards as harmonized as possible with international standards," Beier explained. "The decision-making has to be made on sound science and it has to be quite transparent and predictable." 3. A Visible Intellectual Property System "China has made steps along that road, especially after being accepted in to the World Trade Organization and its intellectual property standards," Beier said. "I think it's not a surprise many Chinese government officials have also said, however, much, much work is necessary…" 4. Will There be a Reward for Innovation? "Will there be a reward, at the end of the day, for creating a product for a serious unmet medical need? Beier asked. "Countries across the world have struggled with this. It's an issue in the United States. It's an issue in Western Europe and most other countries. I hope the Chinese people expect, from their government, payment for innovation." 5. Access to Capital "In an appropriate and typically Chinese way, that access to capital is going to come from a variety of sources," Beier explained.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory